OM:GETI B

Stock Analysis Report

Executive Summary

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.

Snowflake

Fundamentals

Adequate balance sheet and fair value.


Similar Companies

Share Price & News

How has Getinge's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

16.0%

GETI B

4.1%

SE Medical Equipment

2.2%

SE Market


1 Year Return

84.9%

GETI B

38.1%

SE Medical Equipment

16.0%

SE Market

Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned 38.1% over the past year.

Return vs Market: GETI B exceeded the Swedish Market which returned 16% over the past year.


Shareholder returns

GETI BIndustryMarket
7 Day16.0%4.1%2.2%
30 Day11.9%1.6%2.7%
90 Day15.4%1.6%4.2%
1 Year86.4%84.9%39.6%38.1%21.0%16.0%
3 Year33.2%5.1%58.1%39.6%34.5%14.2%
5 Year21.1%-7.0%67.9%40.1%61.7%27.1%

Price Volatility Vs. Market

How volatile is Getinge's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Getinge undervalued compared to its fair value and its price relative to the market?

30.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GETI B (SEK158.3) is trading below our estimate of fair value (SEK229.01)

Significantly Below Fair Value: GETI B is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: GETI B is good value based on its PE Ratio (41.9x) compared to the Medical Equipment industry average (45.5x).

PE vs Market: GETI B is poor value based on its PE Ratio (41.9x) compared to the Swedish market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: GETI B is poor value based on its PEG Ratio (2.2x)


Price to Book Ratio

PB vs Industry: GETI B is good value based on its PB Ratio (2.1x) compared to the SE Medical Equipment industry average (4.4x).


Next Steps

Future Growth

How is Getinge forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

18.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GETI B's forecast earnings growth (18.9% per year) is above the savings rate (0.4%).

Earnings vs Market: GETI B's earnings (18.9% per year) are forecast to grow faster than the Swedish market (8.8% per year).

High Growth Earnings: GETI B's earnings are forecast to grow, but not significantly.

Revenue vs Market: GETI B's revenue (3.8% per year) is forecast to grow slower than the Swedish market (4.5% per year).

High Growth Revenue: GETI B's revenue (3.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GETI B's Return on Equity is forecast to be low in 3 years time (9.7%).


Next Steps

Past Performance

How has Getinge performed over the past 5 years?

-40.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: GETI B's earnings have declined by -40.9% per year over the past 5 years.

Accelerating Growth: GETI B has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: GETI B has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.3%).


Return on Equity

High ROE: GETI B's Return on Equity (5.1%) is considered low.


Return on Assets

ROA vs Industry: GETI B's Return on Assets is below or equal to the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: GETI B's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Getinge's financial position?


Financial Position Analysis

Short Term Liabilities: GETI B's short term assets (SEK14.7B) exceeds its short term liabilities (SEK1.8B)

Long Term Liabilities: GETI B's short term assets (14.7B) do not cover its long term liabilities (23.9B)


Debt to Equity History and Analysis

Debt Level: GETI B's debt to equity ratio (50.9%) is considered high

Reducing Debt: GETI B's debt to equity ratio has reduced from 118.9% to 50.9% over the past 5 years.

Debt Coverage: GETI B's debt is well covered by operating cash flow (26.7%).

Interest Coverage: GETI B's interest payments on its debt are well covered by EBIT (4x coverage).


Balance Sheet

Inventory Level: GETI B has a high level of physical assets or inventory.

Debt Coverage by Assets: GETI B's debt is covered by short term assets (assets are 1.383970x debt).


Next Steps

Dividend

What is Getinge's current dividend yield, its reliability and sustainability?

0.63%

Current Dividend Yield


Dividend Yield vs Market

company0.6%marketbottom25%1.8%markettop25%4.7%industryaverage1.0%forecastin3Years1.4%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: GETI B's dividend (0.63%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.81%).

High Dividend: GETI B's dividend (0.63%) is low compared to the top 25% of dividend payers in the Swedish market (4.71%).

Stable Dividend: GETI B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are stable.

Growing Dividend: GETI B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: GETI B is not paying a notable dividend for the Swedish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GETI B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

What is the CEO of Getinge's salary, the management and board of directors tenure and is there insider trading?

2.6yrs

Average management tenure


CEO

Mattias Perjos (47yo)

2.6yrs

Tenure

kr33,560,000

Compensation

Mr. Mattias Perjos has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serves as Chief Executive Officer at FlexLink Systems, Inc. Mr. Perjos has been the Dire ...


CEO Compensation Analysis

Compensation vs. Market: Mattias's total compensation ($USD3.48M) is about average for companies of similar size in the Swedish market ($USD1.08M).

Compensation vs Earnings: Mattias's compensation has been consistent with company performance over the past year.


Management Age and Tenure

2.6yrs

Average Tenure

52yo

Average Age

Experienced Management: GETI B's management team is considered experienced (2.6 years average tenure).


Board Age and Tenure

5.8yrs

Average Tenure

59yo

Average Age

Experienced Board: GETI B's board of directors are considered experienced (5.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Buykr171,24009 Nov 18
Malin Persson
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares2,000
Max Pricekr85.62
Buykr243,75001 Nov 18
Lars Sandström
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares3,000
Max Pricekr81.25
Buykr263,46031 Oct 18
Johan Bygge
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,000
Max Pricekr87.82

Ownership Breakdown


Management Team

  • Mattias Perjos (47yo)

    CEO, President & Director

    • Tenure: 2.6yrs
    • Compensation: kr33.56m
  • Magnus Lundbäck (50yo)

    Executive Vice President of Human Resources & Sustainability

    • Tenure: 2.8yrs
  • Dieter Engel

    Chief Technology Officer of Surgical Workflows

    • Tenure: 3.8yrs
  • Lena Hagman (54yo)

    Executive Vice President of Quality & Regulatory Compliance

    • Tenure: 3.8yrs
  • Jens Viebke (52yo)

    President of Acute Care Therapies

    • Tenure: 0yrs
  • Lars Sandström (47yo)

    Chief Financial Officer

    • Tenure: 1.8yrs
  • Carsten Blecker (53yo)

    Chief Commercial Officer

    • Tenure: 1.8yrs
  • Abraham Ronai

    General Counsel

    • Tenure: 0yrs
  • Lars Mattson

    Head of Investor Relations

    • Tenure: 0yrs
  • Jeanette Carlsson (53yo)

    Executive Vice President of Communications & Academy

    • Tenure: 2.3yrs

Board Members

  • Johan Bygge (63yo)

    Independent Director

    • Tenure: 12.5yrs
    • Compensation: kr852.00k
  • Carl Bennet (68yo)

    Director

    • Tenure: 30.8yrs
    • Compensation: kr1.31m
  • Malin Persson (51yo)

    Independent Director

    • Tenure: 5.8yrs
    • Compensation: kr684.00k
  • Johan Stern (68yo)

    Vice Chairman

    • Tenure: 0yrs
    • Compensation: kr684.00k
  • Johan Malmqvist (58yo)

    Chairman

    • Tenure: 0.5yrs
    • Compensation: kr684.00k
  • Cecilia Wennborg (56yo)

    Independent Director

    • Tenure: 9.5yrs
    • Compensation: kr722.00k
  • Mattias Perjos (47yo)

    CEO, President & Director

    • Tenure: 2.6yrs
    • Compensation: kr33.56m
  • Barbro Fridén (63yo)

    Independent Director

    • Tenure: 2.6yrs
    • Compensation: kr684.00k
  • Peter Jörmalm (60yo)

    Employee Representative Director

    • Tenure: 1.8yrs
  • Rickard Karlsson (49yo)

    Employee Representative Director

    • Tenure: 6.8yrs

Company Information

Getinge AB's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Getinge AB
  • Ticker: GETI B
  • Exchange: OM
  • Founded: 1904
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr43.116b
  • Shares outstanding: 272.37m
  • Website: https://www.getinge.com

Number of Employees


Location

  • Getinge AB
  • Lindholmspiren 7
  • Gothenburg
  • Västra Götaland County
  • 417 56
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GNGB.FOTCPK (Pink Sheets LLC)YesClass B SharesUSUSDMay 1993
GETI BOM (OMX Nordic Exchange Stockholm)YesClass B SharesSESEKMay 1993
GTNDB (Deutsche Boerse AG)YesClass B SharesDEEURMay 1993
0GZVLSE (London Stock Exchange)YesClass B SharesGBSEKMay 1993
GETIBSBATS-CHIXE (BATS 'Chi-X Europe')YesClass B SharesGBSEKMay 1993
GNGB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDOct 2008

Biography

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapi ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 20:46
End of Day Share Price2019/10/23 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.